Vaccine: upcoming dates

Recent

• Health09/30/2026@ThePinGang

  70,000 Ervebo Doses Released for DRC's Bundibugyo Ebola Outbreak

  Bunia, Ituri Province, Democratic Republic of the CongoWorld Health Organization

  

  Starts 08/17/2026CONFIRMEDDate confidence: CONFIRMEDStated as firmHow firmly the source words the date: confirmed, scheduled, estimated, delayed or unverified.Show all CONFIRMED pins78% CONFIDENCEOverall confidence: 78%How well the pin's source and references back up its dates.Weighted average of how firmly 5 references, the source included, support the pin's start and end times; a reference counts half as much for every 180 days older than the newestShow all pins at 75% confidence or better46 days agoWHO's^[1] 20 August 2026 release says the ICG informed the DRC government 'on Monday' of the immediate initial release, which is Monday 17 August 2026.

  The International Coordinating Group on Vaccine Provision released 70,000 Ervebo doses from the global Ebola stockpile to the DRC: 20,000 for a Phase 3 trial and 50,000 for frontline and health workers. WHO stresses it is not known whether Ervebo protects against Bundibugyo virus.

  00
• Health09/23/2026@HealthDesk

  Lilly Agrees to Buy Three Vaccine Developers for Up to $3.83 Billion

  Eli Lilly and Company Corporate Center, East McCarty Street, Indianapolis, Indiana 46206, United StatesEli Lilly

  

  Starts 05/26/2026CONFIRMEDDate confidence: CONFIRMEDStated as firmHow firmly the source words the date: confirmed, scheduled, estimated, delayed or unverified.Show all CONFIRMED pins87% CONFIDENCEOverall confidence: 87%How well the pin's source and references back up its dates.Weighted average of how firmly 5 references, the source included, support the pin's start and end times; a reference counts half as much for every 180 days older than the newestShow all pins at 75% confidence or better129 days agoLilly's release is datelined "INDIANAPOLIS, May 26, 2026" and says Lilly "today announced agreements to acquire three companies".^[1]

  Lilly moves into infectious disease by agreeing to buy Curevo (shingles), LimmaTech Biologics (staph and other bacteria) and Vaccine Company (Epstein-Barr virus) for up to $3.83 billion combined in cash.

  $3.8B

  30
• Health09/21/2026@HealthDesk

  The Salk Polio Vaccine Is Declared Safe and Effective

  University of Michigan, Ann Arbor, MI 48109, United States

  

  Starts 04/12/1955CONFIRMEDDate confidence: CONFIRMEDStated as firmHow firmly the source words the date: confirmed, scheduled, estimated, delayed or unverified.Show all CONFIRMED pins87% CONFIDENCEOverall confidence: 87%How well the pin's source and references back up its dates.Weighted average of how firmly 2 references, the source included, support the pin's start and end times; a reference counts half as much for every 180 days older than the newestShow all pins at 75% confidence or better71.5 years agoThe field trial results were announced at the University of Michigan on 12 April 1955, the date the announcement itself carries.^[1]

  At Ann Arbor, Thomas Francis Jr announced the results of the largest medical field trial ever run - 1.8 million children - and pronounced Jonas Salk's polio vaccine safe, effective and potent. Church bells rang across the United States; within two years American cases had fallen by almost 90 per cent.

  00